Home > Insider Trading > Filing (0001415889-21-003715)

Filing Details

Accession Number:: 0001415889-21-003715
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-07-26 18:07:56
Reporting Period:: 2021-07-22

Accepted Time:: 2021-07-26 18:07:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1646649	Jonathan Sheena	C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-07-22	187	$5.40	455,817	No	4	M	Direct
Common Stock	Acquisiton	2021-07-22	65	$9.59	455,882	No	4	M	Direct
Common Stock	Acquisiton	2021-07-22	400	$10.41	456,282	No	4	M	Direct
Common Stock	Acquisiton	2021-07-22	700	$9.29	456,982	No	4	M	Direct
Common Stock	Disposition	2021-07-22	887	$121.36	456,095	No	4	S	Direct
Common Stock	Disposition	2021-07-22	300	$122.36	455,795	No	4	S	Direct
Common Stock	Disposition	2021-07-22	165	$123.31	455,630	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-07-22	187	$0.00	187	$5.40
Common Stock	Stock Option (right to buy)	Disposition	2021-07-22	65	$0.00	65	$9.59
Common Stock	Stock Option (right to buy)	Disposition	2021-07-22	400	$0.00	400	$10.41
Common Stock	Stock Option (right to buy)	Disposition	2021-07-22	700	$0.00	700	$9.29

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,328	2024-12-09	No	4	M	Direct
40,335	2026-04-07	No	4	M	Direct
35,280	2027-06-08	No	4	M	Direct
17,346	2028-03-08	No	4	M	Direct

Footnotes

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.15 to $122.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.19 to $123.52 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vested fully and became exercisable on November 20, 2019.
The option shares vested fully and became exercisable on April 1, 2020.
The option shares vested fully and became exercisable on March 21, 2021.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.